Skip to content

Study of early ovarian cancer using sentinel lymph node sampling

Study of early ovarian cancer using sentinel lymph node sampling

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CRIS
Registry ID
KCT0009030
Enrollment
30
Registered
2023-12-08
Start date
2023-12-01
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Under general anesthesia, proper surgical drape is done. For patients whose pathology was confirmed prior to surgery, submucosal injection of 1cc indocyanine green will be injected both in infu

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Age: 19-80 years Pathologically confirmed or clinically suspicious stage 1 and 2 epithelial ovarian cancer patients Those who are diagnosed with epithelial, Non-epithelial ovarian cancer, borderline ovarian cancer No suspicious distal metastasis in CT/MRI or PET Those who are planning staging surgery via laparoscopic or laparotomy ECOG 0-2 Those without certain organ failure WBC = 3,000/mm3 Platelets = 100,000/mm3 Creatinine = 2.0 mg/dL Bilirubin = 1.5 x institutional upper limit normal SGOT, SGPT, and ALP = 3 x institutional upper limit normal Those who signed in informed consent by their own will

Exclusion criteria

Exclusion criteria: Those who are diagnosed other than epithelial, Non-epithelial ovarian cancer, borderline ovarian cancer Suspicious distant metastasis in CT/MRI or PET Clinical stage 3 or more Those who are currently pregnant or breast feeding Those who are diagnosed other cancer within 5 years Those who have severe morbidity or complication

Design outcomes

Primary

MeasureTime frame
Adverse event immediately after and after surgery

Secondary

MeasureTime frame
Adverse event immediately after and after surgery

Countries

Korea, Republic of

Contacts

Public Contactchangho song

Ulsan Univeristy Hospital

yoman0307@hanmail.net+82-2-412-1234

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026